Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Unknown 2Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Tuberculosis 1Sarcoidosis 1Neoplasms 1Lymphoma 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Drug Therapy 219Cyclophosphamide 219Paclitaxel 205apatinib 201Bevacizumab 196camrelizumab 190Fluorouracil 188sintilimab 133Irinotecan 125Blood Specimen Collection 125Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 112Pemetrexed 108anlotinib 105S 1 (combination) 105Leucovorin 102Surveys and Questionnaires 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Bronchoalveolar Lavage × Clear all
NCT02874729 2016-11-25

Assay Development for Cancer Biomarkers

King's College London

Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

NCT01836822 2014-02-12

Bronchoscopic Sampling Techniques in Sarcoidosis

Medical University of Warsaw

Phase NA Unknown
90 enrolled
Lymphoid

Lymphoma, Sarcoidosis, Tuberculosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡